Workshops at Healthtech Partnering Week

Workshops at Healthtech Partnering Week are live webinars designed to educate leaders of fundraising companies on elements of the early-stage landscape often overlooked, which can include patents, recruitment, intellectual property, insurance, financial management, and so much more. Check out some of the great content coming your way this March:

Venture Valuation provides global valuation services by assessing companies and products. Founded in 1999 by Dr. Patrik Frei, Venture Valuation has done over 700 valuations for biotech, pharma, and medtech companies around the world, and supports companies’ growth with entrepreneurial education and industry insight.

The Venture Valuation team is bringing their expertise to Healthtech Partnering Week, March 15-19 with two workshops: Company Valuation for Fundraising and Product Valuation for Deal-Making. Each workshop is designed to provide early-stage founders with practical insight into financing and licensing trends, valuation approaches, licensing negotiations, and finding the right investors and strategic partners.

These skills are a necessary component to the growth of early-stage companies, and we invite all start-ups in life science and healthcare to get to know the Venture Valuation team and take advantage of their expertise by joining us at Healthtech Partnering Week.

Sign up to save on early-bird rates by February 19!

Patrik Frei, PhD CEO Venture Valuation

Gergely Ivanyi, PharmD Business Analyst Venture Valuation

Elias Neuendorf, MSc Business Analyst Venture Valuation

Company Valuation for Fundraising

Instructors: Patrik Frei, PhD, CEO, Venture Valuation
Gergely Ivanyi, PharmD, Business Analyst, Venture Valuation
Valuation is a key aspect of fundraising. An average value assumption for each company in a specific financing stage just does not do it anymore. For entrepreneurs, as for investors, it’s important to understand the value drivers of a company. We are looking at the financing trends of the last years, discuss dos and don’ts when speaking with investors and look at how to value a life science company with no revenues.

Topics include, but are not limited to:

• • Overview financing trends

• Which is the right investor?
• Dos and don’ts
• Company valuation approaches

Product Valuation for Deal-Making

Instructors: Patrik Frei, PhD, CEO, Venture Valuation
Elias Neuendorf, MSc, Business Analyst, Venture Valuation
Companies looking at in- or out-licensing need to understand the value dynamics of their product to negotiate realistic deal-terms. Successful business development depends on understanding the fundamentals as well as keeping up with the latest licensing deal trends. We will be looking at the latest deals including up-front and total deal values for different stages and indications and discuss the fundamental valuation approach to asset/product valuation as a basis to estimate possible licensing deal terms.

Topics include, but are not limited to:

• Overview licensing deal and trends
• How to find the right licensing partner
• Asset/Product valuation approach
• Licensing deal negotiation

If you’re interested in hosting a workshop or panel at Healthtech Partnering Week, our Business Development Team is happy to learn more in order to meet your goals. Contact us to start the conversation!